A new approach to analyzing the utility of immunophenotyping for predicting clinical outcome in acute leukemia. Eastern Cooperative Oncology Group
Paietta, E.; Andersen, J.; Wiernik, P.H.
Leukemia 10(1): 1-4
1996
ISSN/ISBN: 0887-6924 PMID: 8558912 Document Number: 461110
Document emailed within 1 workday
Related Documents
Rowe, J.M.; Andersen, J.W.; Cassileth, P.A.; Oken, M.M.; Bennett, J.M.; Wiernik, P.H. 1992: Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience Leukemia 6(Suppl 4): 75-77Hines, J.D.; Mazza, J.J.; Oken, M.M.; Bennett, J.M.; Adelstein, D.J.; Keller, A.; O'Connell, M.J. 1985: High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase i Pilot Study for the Eastern Cooperative Oncology Group Seminars in Oncology 12(2 Suppl 3: 117-119
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35
Carbone, P.P.; Costello, W. 1976: Eastern Cooperative Oncology Group studies with DTIC (NSC-45388) Cancer Treatment Reports 60(2): 193-198
Wadler, S.; Atkins, M.; Karp, D.; Neuberg, D.; Haynes, H.; Dutcher, J.P. 1998: Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991 Cancer Journal From Scientific American 4(4): 261-268
Moertel, C.G.; Lavin, P.T. 1979: Phase II-IIi chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group Cancer Treatment Reports 63(11-12): 1863-1869
Boros, L.; Tsiatis, A.A.; Neiman, R.S.; Mann, R.B.; Glick, J.H. 1986: Phase Ii Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma Cancer Treatment Reports 70(7): 917-918
Sledge, G.W.; Robert, N.; Sparano, J.A.; Cogleigh, M.; Goldstein, L.J.; Neuberg, D.; Rowinsky, E.; Baughman, C.; McCaskill-Stevens, W. 1995: Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer Seminars in Oncology 22(3 Suppl 6: 105-108
Head, D.R.; Kopecky, K.J.; Willman, C.; Appelbaum, F.R. 1994: Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience Leukemia 8(Suppl): S38-S41
Sledge, G.W.; Robert, N.; Sparano, J.A.; Cobeligh, M.; Goldstein, L.J.; Neuberg, D.; Rowinsky, E.; Baughman, C.; McCaskill-Stevens, W. 1994: Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience Seminars in Oncology 21(5 Suppl 8: 15-18
Watanabe, R.; Murata, M.; Takayama, N.; Tokuhira, M.; Kizaki, M.; Okamoto, S.; Kawai, Y.; Watanabe, K.; Murakami, H.; Kikuchi, M.; Nakamura, S.; Ikeda, Y. 1997: Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS) Thrombosis and Haemostasis 77(4): 641-645
Trump, D.L.; Elson, P.J.; Borden, E.C.; Harris, J.E.; Tuttle, R.L.; Whisnant, J.K.; Oken, M.M.; Carignan, J.R.; Ruckdeschel, J.C.; Davis, T.E. 1987: High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study Cancer Treatment Reports 71(2): 165-169
Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
Rosenthal, S.; Harris, D.T.; Horton, J.; Glick, J.H. 1980: Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 64(10-11): 1115-1117
Ettinger, D.S.; Finkelstein, D.M.; Harper, G.R.; Ruckdeschel, J.C.; Chang, A.Y.; Camacho, F.J.; Marsh, J.C.; Silber, R.; Wolter, J.M. 1985: Phase Ii study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study Cancer Treatment Reports 69(9): 1033-1034
Yuen, A.R.; Fuks, J.Z.; Ettinger, D.S.; Chang, A.Y.; Ruckdeschel, J.C.; Phan, S.C.; Blum, R.H. 2000: Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586) Cancer Journal From Scientific American 6(1): 34-39
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Invernizzi, R.; Rosanda, C.; Basso, G.; Conter, V.; di Cataldo, A.; Fenu, S.; Forni, M.; Frappampina, V.; Granchi, D.; Locatelli, F. 1992: Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias" Haematologica 77(1): 30-34
Zittoun, R.; Mandelli, F.; Willemze, R.; de Witte, T.; Tura, S.; Ferrini, P.R.; Stryckmans, P.; Gattringer, C.; Petti, M.C.; Solbu, G. 1992: Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase IIi trial (AML8 A). the EORTC Leukemia Cooperative Group and the GIMEMA Group Leukemia 6(Suppl 2): 114-115